Cefdinir Powder, For Suspension
Product Images NDC 68071-3156

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 68071-3156). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Cedfinir Monohydrate (3509197f 5b82 408d 81d6 3a41b294c53a 01)

Chemical structure diagram of Cefdinir displayed with a hydrate (H2O) molecule indicated.*

FDA Label Image

68071 3156 6

The label for Cefdinir 125 mg/5 mL oral suspension, 60 mL bottle, from NuCare Pharmaceuticals, Inc. It includes NDC 68071-3156-6, a dosage instruction space for teaspoons and times per day, and warnings to keep out of reach of children and store at 68-77°F. The label also notes Rx Only and refers to the manufacturer's label for full ingredient details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.